Viewing StudyNCT00126880



Ignite Creation Date: 2024-05-05 @ 11:46 AM
Last Modification Date: 2024-10-26 @ 9:13 AM
Study NCT ID: NCT00126880
Status: COMPLETED
Last Update Posted: 2011-06-23
First Post: 2005-08-03

Brief Title: AVX754 a New Nucleoside Reverse Transcriptase Inhibitor NRTI to Treat Drug-resistant HIV
Sponsor: Avexa
Organization: Avexa

Conditions & Keywords Data

Conditions:
Name
HIV Infections
Keywords:
Name View
Treatment Experienced View
Human Immunodeficiency Virus View
anti-retroviral therapy View
nucleoside analogue View
reverse transcriptase View
lamivudine View
resistance mutation View